Zdrowie i gospodarka · 29/05/2001

FDA to Reclassify Autopheresis-C System from Class III to Class II

The FDA is seeking public comment on a recommendation to reclassify the Autopheresis-C System, a device used for routine blood collection, from a Class III to a Class II device, following a petition from Baxter Healthcare Corp.